Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Bibliográfalaš dieđut
Váldodahkkit:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Wiley Open Access 2024

Geahča maid

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
Dahkki: Helia Givian, et al.
Almmustuhtton: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
Dahkki: Jorge Garcia Condado, et al.
Almmustuhtton: (2023-10-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Dahkki: Oulhaj, A, et al.
Almmustuhtton: (2016)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
Dahkki: Michael J. Pearson, et al.
Almmustuhtton: (2024-07-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Dahkki: Ali Azargoonjahromi, et al.
Almmustuhtton: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
Dahkki: Asma Hallab, et al.
Almmustuhtton: (2024-09-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
Dahkki: de Jager, C, et al.
Almmustuhtton: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Dahkki: De Jager, C, et al.
Almmustuhtton: (2012)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
Dahkki: Chen Xue, et al.
Almmustuhtton: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
Dahkki: Chao Wang, et al.
Almmustuhtton: (2024-06-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
Dahkki: Xiaoming Zheng, et al.
Almmustuhtton: (2024-10-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
Dahkki: Lanlan Li, et al.
Almmustuhtton: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
Dahkki: Gerasimos Grammenos, et al.
Almmustuhtton: (2024-04-01)

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods
Dahkki: Baiwen Zhang, et al.
Almmustuhtton: (2024-06-01)

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
Dahkki: Boyue Song, et al.
Almmustuhtton: (2024-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
Dahkki: Zhongzhe Ouyang, et al.
Almmustuhtton: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
Dahkki: Guanan Zhao, et al.
Almmustuhtton: (2024-01-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
Dahkki: Jones, S, et al.
Almmustuhtton: (2017)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
Dahkki: Stockman, CA, et al.
Almmustuhtton: (2024)

Longitudinal accelerated brain age in mild cognitive impairment and Alzheimer’s disease
Dahkki: Maria Ly, et al.
Almmustuhtton: (2024-10-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
Dahkki: Xiao-jun Jing, et al.
Almmustuhtton: (2024-09-01)

Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer’s Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP
Dahkki: Alessia Sarica, et al.
Almmustuhtton: (2024-02-01)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
Dahkki: Moore, P, et al.
Almmustuhtton: (2019)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
Dahkki: Seyed Hossein Nozadi, et al.
Almmustuhtton: (2018-01-01)

Brain age gap estimation using attention-based ResNet method for Alzheimer’s disease detection
Dahkki: Atefe Aghaei, et al.
Almmustuhtton: (2024-06-01)

Homocysteine, B vitamins, and cognitive impairment
Dahkki: Smith, A, et al.
Almmustuhtton: (2016)

Homocysteine, B vitamins, and cardiovascular disease
Dahkki: Refsum, H, et al.
Almmustuhtton: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Dahkki: Refsum, H, et al.
Almmustuhtton: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
Dahkki: Smith, A, et al.
Almmustuhtton: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Dahkki: Smith, A, et al.
Almmustuhtton: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Dahkki: Smith, A, et al.
Almmustuhtton: (2010)

Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline
Dahkki: Hoon Seo, et al.
Almmustuhtton: (2024-05-01)

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease
Dahkki: Yaqiong Xiao, et al.
Almmustuhtton: (2024-05-01)

Multiple phenotype association tests based on sliced inverse regression
Dahkki: Wenyuan Sun, et al.
Almmustuhtton: (2024-04-01)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
Dahkki: Nurk, E, et al.
Almmustuhtton: (2005)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
Dahkki: Palma, M, et al.
Almmustuhtton: (2020)

Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
Dahkki: Colleen Lacey, et al.
Almmustuhtton: (2024-01-01)

The Association among Hypothalamic Subnits, Gonadotropic and Sex Hormone Plasmas Levels in Alzheimer’s Disease
Dahkki: Edward Ofori, et al.
Almmustuhtton: (2024-03-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
Dahkki: Zhengshi Yang, et al.
Almmustuhtton: (2024-01-01)

Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition
Dahkki: Xuan Yang, et al.
Almmustuhtton: (2024-08-01)